Zobrazeno 1 - 10
of 15
pro vyhledávání: '"S Lena Kang-Birken"'
Autor:
Ashlan J. Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M. Lagnf, Taylor Morrisette, Kyle C. Molina, Alaina DeKerlegand, Melanie Rae Schrack, S. Lena Kang-Birken, Athena L.V. Hobbs, Jazmin Agee, Nicholson B. Perkins, Mark Biagi, Michael Pierce, James Truong, Justin Andrade, Jeannette Bouchard, Tristan Gore, Madeline A. King, Benjamin M. Pullinger, Kimberly C. Claeys, Shelbye Herbin, Reese Cosimi, Serina Tart, Michael P. Veve, Bruce M. Jones, Leonor M. Rojas, Amy K. Feehan, Marco R. Scipione, Jing J. Zhao, Paige Witucki, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT Eravacycline is a synthetic fluorocycline approved by the U.S. Food and Drug Administration in 2018. This study aimed to describe clinical and microbiological outcomes in addition to associated adverse effects of eravacycline used in U.S. ho
Externí odkaz:
https://doaj.org/article/c7670c6ad2ab4a279e5ee3917f0e0369
Autor:
Sara Alosaimy, Taylor Morrisette, Abdalhamid M. Lagnf, Leonor M. Rojas, Madeline A. King, Benjamin M. Pullinger, Athena L. V. Hobbs, Nicholson B. Perkins, Michael P. Veve, Jeannette Bouchard, Tristan Gore, Bruce Jones, James Truong, Justin Andrade, Glen Huang, Reese Cosimi, S. Lena Kang-Birken, Kyle C. Molina, Mark Biagi, Michael Pierce, Marco R. Scipione, Jing J. Zhao, Susan L. Davis, Michael J. Rybak
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT Forty-six patients were treated with eravacycline (ERV) for Acinetobacter baumannii infections, where 69.5% of isolates were carbapenem resistant (CRAB). Infections were primarily pulmonary (58.3%), and most patients received combination the
Externí odkaz:
https://doaj.org/article/3784b810c9054f3dafb994059224b8c7
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Abstract Objective: To evaluate oral antibiotic prescribing for common infections at hospital discharge before and after implementation of a pharmacist-driven transitions-of-care (TOC) program. Design: Single-center before-and-after study. Setti
Externí odkaz:
https://doaj.org/article/749225429c874fc69c7468d2fd70e8d6
Autor:
S. Lena Kang-Birken, Elaine J. Law, Yong S. K. Moon, Audrey J. Lee, Andrew L. Haydon, Allen Shek
Publikováno v:
Pharmacy, Vol 10, Iss 5, p 103 (2022)
The coronavirus disease 2019 pandemic created a major shift in learning modalities in the Advanced Pharmacy Practice Experience program. This descriptive study aimed to evaluate preceptor and student perceptions of remote learning experiences and stu
Externí odkaz:
https://doaj.org/article/ca7317dd2b294d1b8e4a01bc169e0ca7
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 18 (2019)
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) is a potent fixed-dose, once-daily regimen for HIV-1 treatment and has rare emergence of drug resistance. We report a potential drug–drug interaction in 2 female patients both
Externí odkaz:
https://doaj.org/article/5318315d7f534204b530982b1dbda90f
Autor:
S Lena Kang-Birken
Publikováno v:
Annals of Pharmacotherapy. 56:330-338
Objective: To evaluate recent publications on efficacy of single-dose azithromycin and 7-day doxycycline when treating Chlamydia trachomatis. Data Sources: A literature search of MEDLINE, EMBASE, PubMed, and Cochrane library was conducted (1990 to Ju
Autor:
Allen Shek, Audrey J Lee, S Lena Kang-Birken, Veronica T. Bandy, Elaine Law, Andrew Haydon, Yong S K Moon, Marie C Scott
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
Purpose To describe the innovative teaching practices, tools, and resources for remote learning developed by a school of pharmacy with a decentralized experiential program to empower and support preceptors in response to the coronavirus disease 2019
Publikováno v:
Infection Control & Hospital Epidemiology. 40:974-978
Objective:To describe the frequency of antibiotic prescriptions in patients with known viral respiratory infections (VRIs) diagnosed by polymerase chain reaction (PCR) in 3 emergency departments (EDs) and to identify patient characteristics that infl
Publikováno v:
Infection Control & Hospital Epidemiology. 42:1523-1523
Publikováno v:
Journal of the International Association of Providers of AIDS Care
Journal of the International Association of Providers of AIDS Care, Vol 18 (2019)
Journal of the International Association of Providers of AIDS Care, Vol 18 (2019)
Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) is a potent fixed-dose, once-daily regimen for HIV-1 treatment and has rare emergence of drug resistance. We report a potential drug–drug interaction in 2 female patients both